ATHIRA PHARMA INC. -
0.6370
27-11月-24 12:19:59
15 分の遅延
株式
+0.0170
+2.74%
本日の幅
0.6100 - 0.6500
ISIN
N/A
ソース
NASDAQ
-
Athira Pharma Presents Preclinical Data at the Alzheimer's Association International Conference 2022
02 8 2022 15:30:00 提供 Nasdaq GlobeNewswire
-
25 7 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
22 6 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
07 6 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
Shareholders Approve the Election of All Three Athira Director Nominees at 2022 Annual Meeting
19 5 2022 12:06:13 提供 Nasdaq GlobeNewswire
-
Athira Issues Statement in Response to Richard A. Kayne’s Suspension of His Proxy Contest
16 5 2022 16:49:31 提供 Nasdaq GlobeNewswire
-
Athira Pharma Presents Preclinical Data at the 2022 Peripheral Nerve Society (PNS) Annual Meeting
16 5 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
12 5 2022 16:05:02 提供 Nasdaq GlobeNewswire
-
Athira Urges Shareholders to Support its Director Nominees at May 19 Annual Meeting
11 5 2022 16:15:00 提供 Nasdaq GlobeNewswire
-
09 5 2022 07:00:02 提供 Nasdaq GlobeNewswire
-
05 5 2022 12:03:56 提供 Nasdaq GlobeNewswire
-
05 5 2022 08:00:03 提供 Nasdaq GlobeNewswire
-
04 5 2022 18:46:09 提供 Nasdaq GlobeNewswire
-
26 4 2022 08:00:03 提供 Nasdaq GlobeNewswire
-
20 4 2022 09:02:06 提供 Nasdaq GlobeNewswire
-
Athira Files Definitive Proxy Statement and Mails Letter to Shareholders
05 4 2022 16:04:20 提供 Nasdaq GlobeNewswire
-
04 4 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
Athira Pharma Highlights Strong Execution of Strategy and Positioning for the Future
30 3 2022 12:12:04 提供 Nasdaq GlobeNewswire
-
Athira Pharma Reports Full Year 2021 Financial Results and Provides Clinical Update
24 3 2022 16:05:01 提供 Nasdaq GlobeNewswire
-
Athira Pharma Announces Appointment of Dr. Michael A. Panzara to its Board of Directors
21 3 2022 07:05:00 提供 Nasdaq GlobeNewswire